CK-3828136
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CK-3828136, covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants [Phase 1]